Observational study of stroke management and outcomes at Akershus University Hospital

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study involves patients with cerebrovascular diseases admitted to the Stroke Unit at Akershus University Hospital in Norway. The study aims to evaluate the use of the stroke fast track, the proportion of patients treated with intravenous thrombolysis, and the reasons for not administering thrombolysis in eligible patients. It will also investigate outcomes for patients treated or not treated with thrombolysis, as well as differences between stroke types and mimics. The research will provide insights into stroke management and care pathways in a comprehensive stroke center.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Cerebrovascular diseases (acute ischemic stroke, intracerebral hemorrhage, transient ischemic attack) or stroke mimics

Exclusion Criteria:

* None

Where it's running

• Akershus University Hospital
  Lørenskog, Norway Recruiting

Study contacts

• Principal investigator: Espen S. Kristoffersen, MD, PhD — University Hospital, Akershus
• Study coordinator: Espen S. Kristoffersen, MD, PhD
• Email: e.s.kristoffersen@medisin.uio.no

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Effectiveness of a new neurorehabilitation technology for stroke recovery

  This study is testing a new rehabilitation technology that uses robots and virtual reality to see if it can help stroke patients recover better than regular therapy.

  Recruiting Neurotechnika · Samara, Samara Oblast · NCT06753006

• Emergency Stroke Unit for treating acute strokes

  This study is testing a new Emergency Stroke Unit that uses a mobile MRI to see if it can help treat stroke patients faster and improve their recovery.

  Recruiting Chinese University of Hong Kong · Hong Kong · NCT06728592

• HR-MRI–Directed Tirofiban Therapy for Late-Window ICAS-LAA Stroke

  We’re testing whether tirofiban plus dual antiplatelet therapy, guided by high-resolution MRI of the brain’s blood vessels, can help people with intracranial large-artery atherosclerosis strokes that begin more than 24 hours after onset.

  Recruiting Phase 3 Weifang Medical University · Weifang, China/Shandong Province · NCT07379190

• Observational study of patients with spontaneous intracerebral hemorrhage

  This study is looking at patients with spontaneous brain bleeding to see how they recover and what long-term effects they might have.

  Recruiting at 6 sites First Affiliated Hospital of Fujian Medical University · Fuzhou, Fujian and 5 other locations · NCT06670456

• Tenecteplase versus alteplase before mechanical thrombectomy for acute large-vessel ischemic stroke

  This trial tests whether tenecteplase given before mechanical thrombectomy helps adults with acute large-vessel ischemic stroke within 4.5 hours recover better than standard alteplase.

  Recruiting Phase 3 Xuanwu Hospital, Beijing · Beijing, Beijing Municipality · NCT06658197

• Examining joint motion problems in stroke patients and healthy volunteers

  This study is testing a physical exam method to see how well it can spot joint motion problems in stroke patients compared to healthy people.

  Recruiting University of California, Davis · Sacramento, California · NCT06605014

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.